Select for export Psychedelics and the Gut Microbiome: Unraveling the Interplay and Therapeutic Implications. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acschemneuro.5c00418 PubMed 40631920 Copy citation Copy BibTeX ACS chemical neuroscience 2025-08-05 Wang X, Jun F, Lin C PubMed Published psilocybin NeuroplasticityPharmacologyMechanism of Action Other More
Select for export Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2025.1594307 PubMed 40842948 Copy citation Copy BibTeX Frontiers in Psychiatry 2025-08-05 Grace Blest-Hopley, Giuseppe Pasculli, Simon Ruffell, WaiFung Tsang, Olateju Emmanuel, Kathryn M. Pate OpenAlex Published psilocybin DepressionAnxietyPTSD Other More
Select for export Between enhancement and risk: A critical review of psychedelic microdosing. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.copsyc.2025.102129 PubMed 40834796 Copy citation Copy BibTeX Unknown journal 2025-08-05 Totomanova I, Haijen ECHM, Hurks PPM, Ramaekers JG, Kuypers KPC. Europe PMC Published psilocybin AnxietyMicrodosingReview Article Review Article More
Select for export Neurobiology of psilocybin: a comprehensive overview and comparative analysis of experimental models Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fnsys.2025.1585367 PubMed 40894380 Copy citation Copy BibTeX Frontiers in Systems Neuroscience 2025-08-04 Dotun Adeleye Adeyinka, Dayna Forsyth, Suzanne Currie, Nicoletta Faraone OpenAlex Published psilocybin DepressionAddictionNeuroplasticity Other More
Select for export A dose of therapy with psilocybin - A meta-analysis of the relationship between the amount of therapy hours and treatment outcomes in psychedelic-assisted therapy. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.genhosppsych.2025.07.020 PubMed 40782561 Copy citation Copy BibTeX Unknown journal 2025-08-04 Hultgren J, Hafsteinsson MH, Brulin JG. Europe PMC Published psilocybin DepressionMeta-Analysis Meta-Analysis More
Select for export Response to emotional stimuli weaker in SSRI users compared with psilocybin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/pu.31349 Copy citation Copy BibTeX The Brown University Psychopharmacology Update 2025-08-03 Authors unavailable OpenAlex Published psilocybin DepressionBrain ImagingMechanism of Action Clinical Trial More
Select for export Latent Classes of Lifetime Use of Seven Hallucinogens in the United States Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2025.2537040 PubMed 40760833 Copy citation Copy BibTeX Journal of Psychoactive Drugs 2025-08-03 Meredith C. Meacham, Maha N. Mian, Ralph C. Wang, Allison R. Coker, B. Anderson, Juan Carlos C. Montoy OpenAlex Published psilocybin Receptor PharmacologyClinical TrialObservational Study Clinical Trial More
Select for export Therapeutic and legal aspects of psilocybin in cancer-related depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2025.1591864 PubMed 40831528 Copy citation Copy BibTeX Frontiers in Psychiatry 2025-08-03 Małgorzata Wierzbicka, Renata Kopczyk, Aleksandra Gerlach, Joanna Rymaszewska OpenAlex Published psilocybinpsilocin DepressionAnxietyPTSD Clinical Trial More
Select for export Interventions to support spirituality among adults with cancer: a scoping review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00520-025-09787-x PubMed 40751754 Copy citation Copy BibTeX Unknown journal 2025-08-01 Miller M, Meyers M, Krainak K, Lewis SP. Europe PMC Published psilocybin End-of-Life DistressWellbeingSpirituality Review Article More
Select for export 204. A NOVEL, NON-HALLUCINOGENIC PSYCHEDELIC FOR THE TREATMENT OF OCD AND TIC DISORDER Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyaf052.019 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2025-07-31 Bernard Lerer, Peretz Golding, Michal Brownstien, Adam Kozikowski, Tzuri Lifschytz OpenAlex Published psilocybin OCDReceptor PharmacologyAnimal Study Animal Study More
Select for export 577. CLINICAL EVIDENCE AND APPLICATIONS OF PSYCHEDELICS FOR MENTAL ILLNESSES Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyaf052.377 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2025-07-31 Hiroe Tani OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export 544. MOLECULAR AND CELLULAR MECHANISMS OF THE LONG-LASTING EFFECTS OF PSYCHEDELICS AND THEIR NON-HALLUCINOGENIC DERIVATIVES Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyaf052.363 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2025-07-31 Argel Aguilar-Valles, Dhiral Kot, Victor Lewis, Gianfilippo Coppola OpenAlex Published psilocybin DepressionNeuroplasticityPharmacology Animal Study More
Select for export 551. PSYCHEDELICS AND OCD: TRANSLATIONAL APPROACHES Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyaf052.368 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2025-07-31 Bernard Lerer, Michal Brownstien, Mitchell A. Lazar, Peter A. Goldstein, Alexander Botvinnik, Alan P. Kozikowski OpenAlex Published psilocybin AnxietyOCDReceptor Pharmacology Animal Study More
Select for export 670. CAN WE RE-MEDICALISE THE PSYCHEDELIC EXPERIENCE? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyaf052.159 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2025-07-31 Guy M. Goodwin OpenAlex Published psilocybin DepressionRandomized Controlled TrialTreatment-Resistant Depression Randomized Controlled Trial More
Select for export Psychedelics as treatment of alcohol use disorders: insights from preclinical models and comparison of the different psychedelics psilocybin, LSD and ketamine No abstract availability was recorded for this entry. Details DOI 10.1016/j.neuroscience.2025.05.064 Copy citation Copy BibTeX Neuroscience 2025-07-31 Mickaël Naassïla OpenAlex Published psilocybin AddictionReceptor PharmacologyAnimal Study Animal Study More
Select for export 519. PSILOCYBIN ASSISTED PSYCHOTHERAPY FOR OBSESSIVE COMPULSIVE DISORDER, BODY DYSMORPHIC DISORDER, AND ANOREXIA NERVOSA: STUDY PROTOCOL No abstract availability was recorded for this entry. Details Copy citation Copy BibTeX Unknown journal 2025-07-31 Authors unavailable Europe PMC Published psilocybin Eating Disorders Other More
Select for export 631. PSILOCYBIN AND KETANSERIN VS RTMS IN TREATMENT-RESISTANT DEPRESSION: ENHANCING TOLERABILITY BY MITIGATING PSYCHEDELIC EFFECTS No abstract availability was recorded for this entry. Details Copy citation Copy BibTeX Unknown journal 2025-07-31 Authors unavailable Europe PMC Published psilocybin DepressionTreatment-Resistant DepressionSafety Other More
Select for export 317. PSILOCYBIN DOES NOT INDUCE CONDITIONED PLACE PREFERENCE, BUT MODIFIES BEHAVIORAL PATTERNS IN SPRAGUE-DAWLEY RATS No abstract availability was recorded for this entry. Details Copy citation Copy BibTeX Unknown journal 2025-07-31 Authors unavailable Europe PMC Published psilocybin General Other More
Select for export 164. PSILOCYBIN DURING THE POSTPARTUM PERIOD INDUCES LONG-LASTING ADVERSE EFFECTS IN BOTH MOTHERS AND OFFSPRING No abstract availability was recorded for this entry. Details Copy citation Copy BibTeX Unknown journal 2025-07-31 Authors unavailable Europe PMC Published psilocybin General Other More
Select for export 620. IDENTIFICATION OF BLOOD BIOMARKERS OF PSILOCYBIN-ASSISTED THERAPY TREATMENT RESPONSE FOR GENERALISED ANXIETY DISORDER No abstract availability was recorded for this entry. Details Copy citation Copy BibTeX Unknown journal 2025-07-31 Authors unavailable Europe PMC Published psilocybin AnxietyBiomarkers Other More
